PO33 Tolérance et sécurité de l’exénatide administré 2x/j chez des patients diabétiques de type 2 : analyse de 3 854 patients issus de 11 études cliniques contrôlées vs comparateurs
Bruce, S, Macconell, L, Brown, C, Bonnard, C, Salaun-Martin, C, Han, J, Nicewarner, D, Okerson, T, Braun, D.K, Bloomgren, G
Published in Diabetes & metabolism (2010)
Published in Diabetes & metabolism (2010)
Get full text
Journal Article
Infections from seven clinical trials of ixekizumab, an anti‐interleukin‐17A monoclonal antibody, in patients with moderate‐to‐severe psoriasis
Papp, K.A., Bachelez, H., Blauvelt, A., Winthrop, K.L., Romiti, R., Ohtsuki, M., Acharya, N., Braun, D.K., Mallbris, L., Zhao, F., Xu, W., Walls, C.D., Strober, B.
Published in British journal of dermatology (1951) (01.12.2017)
Published in British journal of dermatology (1951) (01.12.2017)
Get full text
Journal Article